
Kenvue
Kenvue Inc., a leading American consumer health company, owns renowned brands like Aveeno, Tylenol, and more.
- 10k
- Public

Kenvue Inc., a leading American consumer health company, owns renowned brands like Aveeno, Tylenol, and more.
kenvue.comCrawled Oct 15, 2026
Find information regarding Kenvue’s most recent financial results announcement for the fiscal second quarter.
Find information regarding Kenvue's announcement focusing on second quarter results, to be released on July 20, 2023.
The page describes Kenvue's announcement of the consumer health company's first day of trading on the New York Stock Exchange under ticker symbol NYSE: KVUE.
The page covers Kenvue's participation in the Deutsche Bank dbAccess Global Consumer Conference in June 2023.
View career opportunities, benefits, and more. Come join a diverse, agile, and energized team at Kenvue.
Find more information on how to contact Kenvue as a consumer or media.
The page describes Kenvue's brands, products, people, and history.
Johnson & Johnson de Argentina S.A.C. E. I. describes its practices for information it and its service providers collect through websites and applications it operates and controls.
Johnson & Johnson Personal Care (Chile) S.A. describes its practices for information it and its service providers collect through websites and applications it operates and controls.
Jielutaili (Shanghai) Investment Co., Ltd. describes how it and its service providers collect, use, and disclose information through websites and applications it operates and controls.
Kenvue Germany GmbH says it processes personal data in connection with its website and specified use cases, and explains users' rights.
Albert Invent raises $55 million to bring AI to chemical experiments. Scientists at manufacturing conglomerates Kenvue and Henkel use its AI tools to design experiments.
Oct 2026ForbesNews article
Jim Cramer and portfolio director Jeff Marks review the CNBC Investing Club’s 33-stock portfolio at its September monthly meeting, highlighting six stocks they consider buys. Their favorites are Kimberly-Clark, Bank of New York, Intel, Micron, Meta and FedEx. Cramer also emphasizes becoming more selective about AI exposure and discusses lessons from the portfolio’s recent exit from Corning.
Sep 2026CNBC TechNews article